Teva Pharma (TEVA) Announces U.S. Launch of Generic Abilify; Remains in Patent Litigation with Otsuka
Tweet Send to a Friend
Teva Pharma (NYSE: TEVA) announced the launch of the generic equivalent to Abilify (aripiprazole) Tablets, 2 mg, 5 mg, 10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
